title: A randomized, controlled, double-blind study of the safety and tolerability of Sandimmun Neoral in stable renal transplant patients. Argentine Multicentre Study Group.
authors.affiliation: Hospital Privado de Córdoba-Centro Médico de Córdoba, Argentina.
authors.forename: P U
authors.initials: PU
authors.lastname: Massari
authors.forename: S
authors.initials: S
authors.lastname: Grosso
authors.forename: G
authors.initials: G
authors.lastname: de Boccardo
authors.forename: M C
authors.initials: MC
authors.lastname: Vásquez
authors.forename: R O
authors.initials: RO
authors.lastname: Schiavelli
authors.forename: R R
authors.initials: RR
authors.lastname: Sabbatiello
authors.forename: D H
authors.initials: DH
authors.lastname: Casadei
authors.forename: M C
authors.initials: MC
authors.lastname: Rial
authors.forename: L J
authors.initials: LJ
authors.lastname: Jost
authors.forename: M D
authors.initials: MD
authors.lastname: Túrin
authors.forename: A
authors.initials: A
authors.lastname: Agost Carreño C
authors.forename: E C
authors.initials: EC
authors.lastname: Maggiora
authors.forename: M M
authors.initials: MM
authors.lastname: Gadea
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D012449:Safety; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine